Cancer is the second leading cause of death in Switzerland. Among the different types of cancers, non-small cell lung cancer (NSCLC) kills the most patients and remains largely incurable. Unfortunately, even newly approved therapies can extend the life of patients by only a few months and only few survive the metastatic stadium long-term. Thus, new treatments that attack the cancer in novel ways are sought.
Click here for original story, Discovering new cancer treatments in the ‘dark matter’ of the human genome
Source: Phys.org